Few research have assessed traits in gross sales or Vape Shop use of tobacco products across the EVALI (e-cigarette, E-Liquids Deals or Vape Deals vaping, product use-associated lung harm) outbreak, and Discounted Vape none have assessed the changes in sales of nicotine replacement therapy (NRT) merchandise around the outbreak. We used Nielsen retail sales data to evaluate tendencies in sales of e-cigarettes, Vape Starter Kits cigarettes, and nicotine replacement therapy (NRT) merchandise earlier than, during, Largest Vape Store and after the EVALI outbreak.
Sales tendencies by aggregated state-level EVALI case prevalence (low, medium, and Vape Shop high) were assessed to analyze interstate variations in adjustments of gross sales coinciding with the EVALI outbreak. Monthly unit gross sales of e-cigarettes, cigarettes, and NRT products overall and Vape Shop by product sort were assessed throughout January 2019 through June 2020 through the use of an interrupted time collection mannequin.
